8Portincasa P,Moschetta A,Calamita G,et al.pathobiology of cholesterol gallstone disease:from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formation[J].Current Drug Turgets -Immune,Endocrine&Metabolic Disorders,2003,3:67-81.
9Erpecum KJV,Venneman NG,Portincasa P,et al.Review article:agents affecting gall-bladder motility-role in treatment and prevention of gallstones[J].Aliment Pharmacol ther,2000,14:66-70.
10Tokumine F,Sunagawa T,Shiohira Y,et al.Drug-associated cholelithiasis:a case of sulindac stone formation and the incorporation of sulindac metabolites into the gallstones J.Tokmine,et al,1999,94:2285-2288.
